Ledger.Open graph →
SEC Form D · filed August 8, 2019

Scopus BioPharma Inc

Offering
$600K
Sold
$451K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Twin Grove Capital LLC · Dover, DEDirectorMaxim Medvedev · Moscow, 1ZExec · DirectorDarshan D. Vyas · Orange, CAExec · DirectorMark Leavitt · New York, NYExec · DirectorWalter Marting · Virginia City, NVExec · DirectorNull Groveport General Manager Limited · St. Peter Port, Y7DirectorMorris C. Laster · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗